PLEXUSShoulder & ArmCervicalEstablished

Plexus Brachialis DUO

Shoulder–arm concept following the brachial plexus surface projection.

Documented cutaneous topical composition for the brachial plexus field (C5–C8/T1): the supraclavicular, infraclavicular and axillary surface and the course of the radial, median and ulnar nerves.

Label QR

Opens the public information page in the reader's language.

https://www.siriamlab.com/qr/plexus-brachialis

Open patient page

Professional documentation →

Essential reading. The complete scientific monograph is one click away.

Chapter 01

Product identity

Identification, classification, family, intended use, anatomical region and the documents this record is governed by.

Identification of the record: product identifier, classification, family, intended use, anatomical region and the controlled documents it is governed by.

Documentation metadata+

Chapter 01 — related anatomy

shoulder-arm

Related documents

PF-PBR-1.3Plexus Brachialis DUO — product formula cardIn preparation

Future references

GTIN / label identifierReservedCommercial identifier reserved for the published label.

Record identification

DocumentedVersion1.3

Product ID: SIR-PBR-01
Family: PLEXUS BRACHIALIS DUO
Region: Cervical — supraclavicular projection
Last update: 2025-12

Handbook source

HB-PBRApproved

Neurodermal modulation of the brachial plexus and the peripheral afferent input of dermatomes C5–C8.

Phase 1: peripheral neurogenic discharge and neuro-inflammatory modulation
Phase 2: neurogenic stabilisation and fascial glide integration

Developer: MT DO, DCP
Pharmacist: AVA
Chapter version: 1.0
Product ID: SIR-PBR-01

The handbook is the scientific master. Every statement rendered on this record originates from this chapter; the platform never creates independent scientific content.

Chapter 02

Executive summary

The record in short: professional summary, patient summary and the sequential treatment model behind it.

The record read in short: professional summary, patient summary and the sequential treatment model behind the formulation.

Documentation metadata+

Chapter 02 — related anatomy

Declared; content in preparation.

Related documents

SDR-001SIRIAM digital record standard

Future references

TranslationsReservedExecutive summary in Dutch, French and German.

Executive summary

SDR-001

The reading entry of the record: what the composition is for, in professional and in patient language.

Purpose

PLEXUS BRACHIALIS DUO gives practitioners a clearly delimited shoulder–arm field, with a two-step texture sequence that keeps daily routines reproducible.

Clinical goal

Regional comfort routineStructured daily applicationProfessional protocol support

Primary anatomical region

shoulder-arm

Primary therapeutic objective

Documented cutaneous topical composition for the supraclavicular and shoulder-girdle field.

Professional summary

Plexus Brachialis DUO is documented as a cutaneous topical composition for the shoulder-arm application field. This summary is maintained by the documentation team and updated with each revision of the record.

Patient summary

Shoulder–arm concept following the brachial plexus surface projection.

Keywords

Plexus Brachialis DUOPLEXUSshoulder-armC5C6C7C8brachial

Chapter 03

Anatomy snapshot

The anatomical region of the record and every structure of its application field, resolving into the Neuro Atlas.

The anatomical identity of the record: the region, the segmental levels and the surface territory the formulation is documented for.

Documentation metadata+

Chapter 03 — related anatomy

shoulder-armC5C6C7C8

Related documents

RM-01Anatomical reference manual

Future references

3D Atlas referenceReservedVolumetric reference of the field, prepared for the atlas engine.
EMG referenceReservedFunctional EMG dataset linked to the segmental levels of this record.
SRST referenceReservedSegmental reflex surface topography mapping.

Snapshot

Anatomy snapshot

Six metameric expressions per segment — dermatome, myotome, sclerotome, viscerotome, micro-angiotome and neurotome. Individual structures inside an expression open their own illustration plate.

Application zones

Anatomical regionShoulder & Arm · Cervical field

DermatomesC5 C6 C7 C8 T1

Peripheral nervesAxillary nerve Musculocutaneous nerve Radial nerve Median nerve Ulnar nerve Supraclavicular nerves

PlexusBrachial plexus

MetamersC5 C6 C7 C8 T1

Neurocutaneous regionCervicothoracic neurocutaneous zone

Application zones

Clinical objectiveRegional comfort routine · Structured daily application · Professional protocol support

Application systemSingle-phase formulation

Atlas layersBody regionsDermatomesPeripheral nervesPlexusesMetamersNeurocutaneous

Anatomical identity

Chapter 01

Primary region

shoulder-arm

Dermatomes

C5C6C7C8T1

Peripheral nerves

axillarymusculocutaneousradialmedianulnarsupraclavicular

Plexus

brachial

Metamers

C5C6C7C8T1

Neurocutaneous territories

cervicothoracic

Body regions

shoulder-arm

Surface anatomy

Lower shoulder girdleUpper armUnder armNerve paths

3D Atlas referenceReservedVolumetric field reference.
EMG referenceReservedFunctional EMG dataset.
SRST referenceReservedSegmental reflex surface topography.

Chapter 04

Clinical purpose

Objective, strategy, workflow and the boundaries within which this record is documented.

The clinical objective of the record, its rationale, and the boundaries within which it is documented.

Documentation metadata+

Chapter 04 — related anatomy

cervicothoracic

Related documents

RM-02Formulation record manual

Future references

Evidence levelReservedGraded evidence classification per documented statement.
Clinical casesReservedStructured practitioner observations linked to this record.

Purpose

Why this formulation exists

Why this record exists

PLEXUS BRACHIALIS DUO gives practitioners a clearly delimited shoulder–arm field, with a two-step texture sequence that keeps daily routines reproducible.

Neurocutaneous region it was designed for

Cervicothoracic neurocutaneous zone

Anatomical interface it addresses

Upper limb territories following the brachial plexus and its terminal branches.

Clinical philosophy

The brachial plexus emerges between the scalene muscles into the supraclavicular fossa, passes under the clavicle and through the axilla before dividing into the radial, median and ulnar nerves that serve the entire upper limb.

Cutaneous topical composition; the application field is defined by the treating professional.
Application is documented per session so routines remain comparable over time.

Chapter 05

Application protocol

Timeline, application sites, professional and patient instructions, safety and storage.

Phases, cadence, duration, zone order and the documented application sequence, with practitioner and patient notes.

Documentation metadata+

Chapter 05 — related anatomy

Lower shoulder girdleUpper armUnder armNerve paths

Related documents

SOP-01Application documentation

Future references

Printable protocolReservedPrint-ready protocol sheet generated from this record.

Surface

Application zones

The zones listed are possible application locations. The practitioner identifies the exact spot within these possibilities using the SRST (Segmental Reflex Sensitisation Test). Future evaluation will use EMG before and after application.

Lower shoulder girdle
Detailed application guidance is in preparation.
Application field
Upper arm
Detailed application guidance is in preparation.
Application field
Under arm
Detailed application guidance is in preparation.
Application field
Nerve paths
Detailed application guidance is in preparation.
Application field

Regional comfort routineStructured daily applicationProfessional protocol support

Protocol

Application protocol

Phase 1
Nerve release
Week 1–2, 1–2 applications per day
Applied first at every session
The first texture is applied thinly over the lower shoulder girdle and below the armpit, then over the upper arm and under arm in the skin field of the affected nerve, and finally along the nerve paths towards the fingertips. Zone order stays identical at every session.
Lower shoulder girdleUpper armUnder armNerve paths
Phase 2
Nerve integration
Two minutes after phase 1
Closes every session
After a two-minute pause the second, lighter texture is applied over the identical field in the same order. From week 3 the morning application uses phase 2 and the evening phase 1; from week 4 onwards phase 2 is used.
Lower shoulder girdleUpper armUnder armNerve paths

Zone sequence

01Lower shoulder girdle
02Upper arm
03Under arm
04Nerve paths

01Cleanse and dry the four defined application zones.
02Apply step one thinly in the order lower shoulder girdle → upper arm → under arm → nerve paths.
03Allow two minutes before applying step two over the identical zones.
04Use as agreed with your healthcare professional.

C5 C6 C7 C8 T1

Application field on the atlas figure. Levels resolve into the Neuro Atlas.

Region definition

The four official zones are delimited: the lower shoulder girdle including the area under the armpit, the upper arm above the elbow, the under arm below the elbow and the nerve paths of the affected peripheral nerve from shoulder to fingertips.

Sequence

Step one, pause, step two — kept identical across sessions for comparability.

Documentation

Frequency and duration are recorded in the professional log sheet.

PLEXUS BRACHIALIS protocol (definitive)

HB-PBR/PROTOCOLApproved

Zones

Supraclavicular
Infraclavicular
Axilla
Nerve course (radial · median · ulnar)

Week 1–2
PLEXUS BRACHIALIS-1
Week 3
Morning: PLEXUS BRACHIALIS-2 · Evening: PLEXUS BRACHIALIS-1
Week 4 onwards
PLEXUS BRACHIALIS-2

On relapse: reintroduce PLEXUS BRACHIALIS-1 for 3 days.

Chapter 06

Formulation science

The scientific philosophy of the composition: sequential formulation, phase relationship and ingredient rationale.

The composition read as an architecture, with the current formula held read-only and any proposed successor documented alongside it.

Documentation metadata+

Chapter 06 — related anatomy

Declared; content in preparation.

Related documents

PFPlexus Brachialis DUO — product formula cardIn preparationRM-001Ingredient libraryReservedRM-008Change controlReserved

Future references

Ingredient linksReservedEvery constituent resolving to its RM-001 entry.
Version comparisonReservedSide-by-side comparison of current and proposed composition.

Composition

Formulation architecture

The composition is documented as a map rather than a list. Every constituent is recorded with the function it carries, the reason it is present in this field, how it relates to the rest of the composition and the cutaneous topical formulation category it belongs to.

Carrier systemMineral constituentSulphur constituentLipid constituentBotanical extractHomeopathic preparationBotanical oil macerateBotanical oleoresinBotanical constituentHumectantConditioning agentAntioxidant stabiliserMineral gelPreservation

01Lanette cream FNA
Carrier system
Functional role
Base — phase 1 and phase 2
Formulation purpose
The emulsion base of both phases; carries every other constituent evenly over the application zone.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
02Aqua purificata
Aqua
Carrier system
Functional role
Water phase — phase 1 and phase 2
Formulation purpose
Sets the water phase that determines spreadability across the defined surface field.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
03Magnesium chloride
Mineral constituent
Functional role
Water-phase constituent — phase 1 and phase 2
Formulation purpose
Documented mineral constituent of both phases, dissolved in the water phase.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
04MSM
Dimethyl sulfone
Sulphur constituent
Functional role
Water-phase constituent — phase 1 and phase 2
Formulation purpose
Documented sulphur constituent of both phases, kept at a level that keeps the texture light.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
05Palmitoylethanolamide (PEA)
Lipid constituent
Functional role
Dispersed constituent — phase 1 and phase 2
Formulation purpose
Documented lipid constituent, separately dispersed before it enters the base.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
06Boswellia serrata
Botanical extract
Functional role
Botanical constituent — phase 1 and phase 2
Formulation purpose
Documented botanical constituent of both phases.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
07Hypericum perforatum D6
Hypericum Perforatum
Homeopathic preparation
Functional role
Homeopathic addition — phase 1 and phase 2
Formulation purpose
Documented homeopathic addition in D6 dilution in both phases.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
08Ginkgo biloba
Botanical extract
Functional role
Botanical constituent — phase 1
Formulation purpose
Documented botanical constituent of the release phase.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
09Ruta graveolens
Homeopathic preparation
Functional role
Release layer — phase 1
Formulation purpose
Documented constituent of the release phase only.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
10Arnica oil
Prunus Amygdalus Dulcis Oil, Arnica Montana Flower Extract
Botanical oil macerate
Functional role
Botanical addition — phase 1
Formulation purpose
Organic Arnica montana flower macerate in cold-pressed sweet almond oil; documented constituent of phase 1 only.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
11Bacopa monnieri
Botanical extract
Functional role
Integration layer — phase 2
Formulation purpose
Documented constituent of the integration phase only.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
12Blue Lotus (Nymphaea caerulea)
Botanical extract
Functional role
Integration layer — phase 2
Formulation purpose
Documented constituent of the integration phase only.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
13Copaiba
Botanical oleoresin
Functional role
Lipid-affine constituent — phase 1 and phase 2
Formulation purpose
Documented oleoresin constituent, added late in the process at low temperature.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
14α-Bisabolol
Bisabolol
Botanical constituent
Functional role
Dermal support — phase 1 and phase 2
Formulation purpose
Documented dermal constituent of both phases.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
15Betaine (TMG)
Betaine
Humectant
Functional role
Water-phase constituent — phase 1 and phase 2
Formulation purpose
Documented humectant constituent of both phases.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
16D-Panthenol
Panthenol
Conditioning agent
Functional role
Surface conditioning — phase 1 and phase 2
Formulation purpose
Documented conditioning constituent; contributes to a smooth, non-tacky finish.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
17Vitamin E
Tocopherol
Antioxidant stabiliser
Functional role
Formulation stability — phase 1 and phase 2
Formulation purpose
Protects the lipid fraction so successive batches stay comparable.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
18Silicea Gel
Mineral gel
Functional role
Water-phase constituent — phase 1 and phase 2
Formulation purpose
Documented mineral gel constituent of the water phase.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.
19COSGARD
Benzyl alcohol, dehydroacetic acid
Preservation
Functional role
Preservation — phase 1 and phase 2
Formulation purpose
Preservation system that keeps the composition stable over its stated period of use.
Interaction within the composition
Combined so that carrier, sensory and skin-feel functions support one another across the documented field.

Reading the map

Constituents are grouped by formulation category: a carrier system that governs spread, a water phase that governs feel, a lipid phase that governs stay-time, and stabilising constituents that keep successive batches comparable. Interactions describe the composition only; no physiological effect is asserted.

Cutaneous topical formulation rationale

The formulation is built for reproducible application on the documented zones: a texture that spreads thinly, a controlled sensory profile and a composition suitable for repeated professional use.

Representative composition overview. The full INCI listing is published in the composition index.

Chapter 07

QR patient information

The label surface, generated from the digital record: what the formulation is, its timeline, application areas, safety and quality assurance.

The label surface of the record, generated from the digital record so patient information can never drift from the documentation.

Documentation metadata+

Chapter 07 — related anatomy

Lower shoulder girdleUpper armUnder armNerve paths

Related documents

Appendix DQR standardReserved

Future references

Printed QRReservedProduction-ready QR code bound to the published version.

Documentation

Downloads

Plexus application protocolsPDF · 1.5 MB · ProfessionalRequest →
Composition and ingredient indexPDF · 0.9 MB · OpenRequest →
QR label packZIP · 6.1 MB · ProfessionalRequest →

Label

QR resources

Each package carries a QR code that resolves to this documentation record in the reader's language, together with the composition index and the current application protocol. Codes are versioned, so updated documentation reaches practitioners without relabelling.

Resolves to /products/plexus-brachialis

QR information

Label resource

Current QR resolves to: /products/plexus-brachialis
Current version: 1.3
Last update: 2025-12
Batch number: PBR-2512

Storage information

Store closed, upright and away from direct sunlight. Storage conditions are documented on the label and repeated here without alteration.

Professional information

Professional reading opens the complete monograph: anatomy, composition architecture, protocol and revision record.

Patient information

Essential reading describes what the composition is, where it is applied and in which order, without clinical interpretation.

Multilingual QR contentReservedReserved: Dutch, English, French and German resolution of the same record.

Quality system

Version control

The current composition and any proposed successor are documented side by side. Approval and change control are handled outside the platform.

Current formula

Approved

Version: 1.3
Revision date: 2025-12

Current approved composition.

Proposed formula

Not issued

No successor is currently proposed for this record.

QR information

Active

QR target: /products/plexus-brachialis
Batch reference: PBR-2512
Record status: Documented

The QR code printed on the label resolves to this record. The product page is the single source of truth; printed material never carries content that is not documented here.

Controlled documents →

Continue

Explore further

Adjacent fieldCTO DUOCervicothoracic zone concept, developed for the transition between neck and upper back.Open →AnatomyNeuro AtlasThe segmental objects of this record inside the layered atlas.Open →MethodApplication protocolsHow a surface field is delimited, covered and documented.Open →ResearchResearch modulesEducational modelling, method notes and modules in preparation.Open →CompositionRelated ingredientsThe composition index: full INCI listing and functional role per constituent.Open →

Cutaneous topical formulation. Information is provided for education and professional reference; it is not medical advice and implies no therapeutic effect.

Back to the ecosystem →

Product identity

Executive summary

Anatomy snapshot

Anatomy snapshot

Clinical purpose

Why this formulation exists

Application protocol

Application zones

Application protocol

Nerve release

Nerve integration

Region definition

Sequence

Documentation

Formulation science

Formulation architecture

QR patient information

Downloads

QR resources

Version control

Explore further